|
Coumarins
Citations 51-60 of 75 total displayed.
|
Past content
(since Nov 2000):
|
- Clinician Update
Pulmonary Embolism After Coronary Artery Bypass Grafting
- Samuel Z. Goldhaber and U. Joseph Schoepf
Circulation 2004;109:2712-2715, doi:10.1161/01.CIR.0000132616.89315.34
[Full text]
- Clinical Investigations and Reports
Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study
- The AFFIRM Investigators
Circulation 2004;109:1509-1513; published online before print as doi:10.1161/01.CIR.0000121736.16643.11
[Abstract]
[Full text]
- Articles
Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study
- The AFFIRM Investigators
Circulation published March 8, 2004, doi:10.1161/01.CIR.0000121736.16643.11
[Abstract]
- Clinical Investigations and Reports
Safety and Efficacy of Enoxaparin Compared With Unfractionated Heparin and Oral Anticoagulants for Prevention of Thromboembolic Complications in Cardioversion of Nonvalvular Atrial Fibrillation: The Anticoagulation in Cardioversion using Enoxaparin (ACE) Trial
- Christoph Stellbrink, Uwe Nixdorff, Thomas Hofmann, Walter Lehmacher, Werner Günther Daniel, Peter Hanrath, Christoph Geller, Andreas Mügge, Walter Sehnert, Caroline Schmidt-Lucke, Jan-André Schmidt-Lucke on Behalf of the ACE (Anticoagulation in Cardioversion using Enoxaparin) Study Group
Circulation 2004;109:997-1003; published online before print as doi:10.1161/01.CIR.0000120509.64740.DC
[Abstract]
[Full text]
- Articles
Safety and Efficacy of Enoxaparin Compared With Unfractionated Heparin and Oral Anticoagulants for Prevention of Thromboembolic Complications in Cardioversion of Nonvalvular Atrial Fibrillation. The Anticoagulation in Cardioversion using Enoxaparin (ACE) Trial
- Christoph Stellbrink, Uwe Nixdorff, Thomas Hofmann, Walter Lehmacher, Werner Günther Daniel, Peter Hanrath, Christoph Geller, Andreas Mügge, Walter Sehnert, Caroline Schmidt-Lucke, Jan-André Schmidt-Lucke on Behalf of the ACE (Anticoagulation in Cardioversion using Enoxaparin) Study Group
Circulation published February 16, 2004, doi:10.1161/01.CIR.0000120509.64740.DC
[Abstract]
- Correspondence
Prosthetic Heart Valves and Pregnancy • Response
- Claire McLintock, Robyn A. North, Harvey D. White, Lynne Hung, and Shahbudin H. Rahimtoola
Circulation 2003;108:e159-160e, doi:10.1161/01.CIR.0000102966.93922.B1
[Full text]
- Review: Clinical Cardiology: New Frontiers
Acute Pulmonary Embolism: Part II: Risk Stratification, Treatment, and Prevention
- Samuel Z. Goldhaber and C. Gregory Elliott
Circulation 2003;108:2834-2838, doi:10.1161/01.CIR.0000098427.74047.42
[Full text]
- Review: Clinical Cardiology: New Frontiers
Acute Pulmonary Embolism: Part I: Epidemiology, Pathophysiology, and Diagnosis
- Samuel Z. Goldhaber and C. Gregory Elliott
Circulation 2003;108:2726-2729, doi:10.1161/01.CIR.0000097829.89204.0C
[Full text]
- Cardiology Patient Pages
Factor V Leiden
- Deborah L. Ornstein and Mary Cushman
Circulation 2003;107:e94-97e, doi:10.1161/01.CIR.0000068167.08920.F1
[Full text]
- AHA/ACC Scientific Statement
American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy
- Jack Hirsh, Valentin Fuster, Jack Ansell, and Jonathan L. Halperin
Circulation 2003;107:1692-1711, doi:10.1161/01.CIR.0000063575.17904.4E
[Full text]
|
|
